retatrutide phase 2 nejm weight loss 48 weeks percent vs Survodutide: 24% vs 18% Explained Eli Lilly's retatrutide shows promising

Strategies to preserve lean mass are discussed, followed by approaches to prevent and manage GI side effects and complications to support treatment adherence

Drug development for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction-associated steatohepatitis (MASH), has been surprisingly challenging 1

Red flag: severe constipation with pain, vomiting, or inability to pass gasseek medical care

Patients should be advised to: Monitor blood glucose levels more frequently if consuming alcohol Avoid drinking on an empty stomach Be aware of delayed hypoglycaemia, which can occur several hours after drinking Ensure companions recognise signs of hypoglycaemia Pancreatitis is a rare but serious adverse effect associated with GLP-1 receptor agonists